Pulished Date August, 2019
ID: 5366
Share on
Share on

Asia Pacific Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: August, 2019
ID: 5366
Pages: 145

A medical procedure is referred to as non- invasive when there is slight incision in body in diagnosis. There are various non- invasive diagnostics methods which range from simple observation to specialized surgery.

Asia Pacific Non-Invasive Cancer Diagnostics Market is worth USD xx million in 2018 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2023. The Asia Pacific Non-Invasive Cancer Diagnostics market is developing at an exceptionally quick pace.

The significant drivers are increasing incidence of cancer due aging, and increasing awareness about early cancer diagnosis. Advancements in cancer detection techniques is also expected to drive the market over the forecast period. However, high cost of treatment is a major restraint limiting this industry.

The Asia Pacific Non-Invasive Cancer Diagnostics market is segmented on the basis of therapeutics, techniques, and region. Based on therapeutics the market is segmented into Blood cancer, Breast Cancer, Lung Cancer, Solid tumors and others. Breast cancer had the largest market share. Based on techniques the market is segmented into Immunochemistry, Clinical Chemistry, Molecular Diagnostics, and Others.

Asia Pacific is geographically segmented into China, India,Japan and South East Asia. Asia Pacific has significant growth owing to growing population and growing government initiatives.

Precision Therapeutics, Laboratory Corporation of America Holdings (LabCorp), BIOVIEW Inc.,   Affymetrix Inc., AVIVA Biosciences Corporation, A&G Pharmaceutical, Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation and Gen-Probe Incorporated, are the key players in the Asia Pacific Non-Invasive Cancer Diagnostics market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Techniques                 

                                5.1.1 Introduction           

                                5.1.2 Clinical Chemistry 

                                5.1.3 Immunochemistry/Immunoassay 

                                5.1.4 Molecular Diagnostics        

                                5.1.5 Other Clinical Instruments

                                5.1.6  Y-o-Y Growth Analysis, By Techniques       

                                5.1.7  Market Attractiveness Analysis, By Techniques     

                                5.1.8  Market Share Analysis, By Techniques       

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Breast Cancer        

                                5.2.3 Blood cancer          

                                5.2.4 Lung Cancer            

                                5.2.5 Solid tumors           

                                5.2.6 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Techniques

                                                6.1.3.3 By Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Techniques

                                                6.1.4.3 By Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Techniques

                                                6.1.5.3 By Type

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 AVIVA Biosciences Corporation                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Affymetrix Inc.                          

                8.3 A&G Pharmaceutical                              

                8.4 BIOVIEW Inc.                             

                8.5 Digene Corporation                

                8.6 Gen-Probe Incorporated                      

                8.7 Laboratory Corporation of America Holdings (LabCorp)                          

                8.8 Precision Therapeutics                          

                8.9 Quest Diagnostics Incorporated                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  •  Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and  with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  2. Asia Pacific Clinical Chemistry Market By Region, From 2018-2023 ( USD Million )
  3. Asia Pacific Immunochemistry/Immunoassay Market By Region, From 2018-2023 ( USD Million )
  4. Asia Pacific Molecular Diagnostics Market By Region, From 2018-2023 ( USD Million )
  5. Asia Pacific Other Clinical Instruments Market By Region, From 2018-2023 ( USD Million )
  6. Asia Pacific Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )
  7. Asia Pacific Breast Cancer Market By Region, From 2018-2023 ( USD Million )
  8. Asia Pacific Blood cancer Market By Region, From 2018-2023 ( USD Million )
  9. Asia Pacific Lung Cancer Market By Region, From 2018-2023 ( USD Million )
  10. Asia Pacific Solid tumors Market By Region, From 2018-2023 ( USD Million )
  11. Asia Pacific Others Market By Region, From 2018-2023 ( USD Million )
  12. Japan Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  13. Japan Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )
  14. China Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  15. China Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )
  16. India Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  17. India Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )
  18. Australia Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  19. Australia Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )
  20. South Korea Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2018-2023 ( USD Million )
  21. South Korea Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2018-2023 ( USD Million )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample